X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Strides Arcolab Fact Sheet, Strides Arcolab Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Strides Arcolab Fact Sheet   (PLLB)

Here is the latest financial fact sheet of Strides Arcolab. For more details, see the Strides Arcolab quarterly results and Strides Arcolab share price and chart. For a sector overview, read our pharmaceuticals sector report.

STRIDES SHASUN LTD Price History

Price Rs 685.7
Mkt Cap Rs m 40,899
Vol '000 19.5
P/E X 13.0
P/CF X 9.4
EPS (TTM) Rs 52.7
% ch % -2.1
No. of shares m 59.65
% ch week % -4.2
% ch 1-mth % -14.2
% ch 12-mth % -40.6
52 week H/L Rs 1,194.0/640.7
(As on Feb 22, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

STRIDES SHASUN LTD Financials

No. of Mths
Year Ending
12
Dec-12
*
15
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
STRIDES SHASUN LTD EQUITY SHARE DATA
High Rs1,2251,1381,1991,4131,275 
Low Rs372344384848918 
Sales per share (Unadj.) Rs163.6225.1200.6320.3389.6 
Earnings per share (Unadj.) Rs143.9296.6141.713.228.0 
Diluted earnings per shareRs141.9296.2141.719.841.9 
Cash flow per share (Unadj.) Rs149.2306.1152.527.948.9 
Dividends per share (Unadj.) Rs2.00505.00108.005.004.50 
Adj. dividends per shareRs1.97504.32107.957.496.75 
Dividend yield (eoy) %0.368.213.70.40.4 
Book value per share (Unadj.) Rs344.6169.0193.9297.5303.1 
Adj. book value per shareRs339.7168.8193.8445.6454.4 
Shares outstanding (eoy) m58.8059.5759.6289.3589.42 
Bonus/Rights/Conversions  ESOPESOPESOPESOPESOP 
Price / Sales ratio x4.93.33.93.52.8 
Avg P/E ratio x5.52.55.685.539.2 
P/CF ratio (eoy) x5.42.45.240.522.4 
Price / Book Value ratio x2.34.44.13.83.6 
Dividend payout %1.4170.376.237.816.1 
Avg Mkt Cap Rs m46,95844,13547,165100,98898,036 
No. of employees `0002.71.52.04.75.8 
Total wages/salary Rs m1,2031,5721,7213,5775,881 
Avg. sales/employee Rs Th3,562.18,939.55,979.36,102.86,005.9 
Avg. wages/employee Rs Th445.61,047.9860.3762.71,014.0 
Avg. net profit/employee Rs Th3,134.211,778.34,225.0251.9431.2 
STRIDES SHASUN LTD INCOME DATA
Net Sales Rs m9,61813,40911,95928,62234,834 
Other income Rs m3426023869211,686 
Total revenues Rs m9,96014,01212,34429,54336,520 
Gross profit Rs m1,0062,2342,2894,1406,428 
Depreciation Rs m3095656401,3131,872 
Interest Rs m7951,0894741,6822,269 
Profit before tax Rs m2451,1831,5602,0673,973 
Minority Interest Rs m-11-6600 
Prior Period Items Rs m000-474 
Extraordinary Inc (Exp) Rs m8,34019,7368,361-414-1,006 
Tax Rs m1123,2451,476425470 
Profit after tax Rs m8,46217,6678,4501,1812,501 
Gross profit margin %10.516.719.114.518.5 
Effective tax rate %45.5274.394.620.511.8 
Net profit margin %88.0131.870.74.17.2 
STRIDES SHASUN LTD BALANCE SHEET DATA
Current assets Rs m14,10913,08614,44735,14938,165 
Current liabilities Rs m17,9737,07410,02218,92030,402 
Net working cap to sales %-40.244.837.056.722.3 
Current ratio x0.81.81.41.91.3 
Inventory Days Days16848637877 
Debtors Days Days18399112132104 
Net fixed assets Rs m15,6795,5068,40035,68237,639 
Share capital Rs m588596596894894 
"Free" reserves Rs m18,0394,59410,96225,68526,210 
Net worth Rs m20,26210,06811,55826,57927,105 
Long term debt Rs m7,3122,7552,53026,27016,377 
Total assets Rs m47,97520,99024,80574,55981,168 
Interest coverage x1.32.14.32.22.8 
Debt to equity ratio x0.40.30.21.00.6 
Sales to assets ratio x0.20.60.50.40.4 
Return on assets %19.389.436.03.85.9 
Return on equity %41.8175.573.14.49.2 
Return on capital %34.0171.673.86.212.1 
Exports to sales %53.059.460.253.10 
Imports to sales %15.720.523.515.90 
Exports (fob) Rs m5,0997,9597,20415,1920 
Imports (cif) Rs m1,5152,7522,8094,5650 
Fx inflow Rs m6,48222,79113,03116,61213,465 
Fx outflow Rs m1,8263,0883,1655,2924,076 
Net fx Rs m4,65619,7039,86511,3209,389 
STRIDES SHASUN LTD CASH FLOW
From Operations Rs m 1,343 -2,717 834 733 2,881 
From Investments Rs m 8,065 40,771 519 -22,248 -7,051 
From Financial Activity Rs m -9,900 -33,185 -4,213 29,439 3,382 
Net Cashflow Rs m -492 4,869 -2,860 7,924 -788 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 27.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 37.8%
FIIs 8.6%
ADR/GDR 0.0%
Free float 25.9%
Shareholders 56,241
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 201, Devavrata, Sector 17, Vashi, Navi Mumbai - 400 705
E-MAIL badree.komandur@stridesarco.com WEB www.stridesarco.com
TELEPHONE (080) 6784 0000 FAX (080) 6784 0800
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Deepak Vaidya (MD) COMP SEC: Badree Komandur (EVP-Finance) YEAR OF INC: 1980 BSE CODE: 532531 FV (Rs): 10 DIV YIELD (%): 1.0

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  FDC LTD.  PLETHICO PHARMA  ASTRAZENECA PHARMA  VENUS REMEDIES  

Compare STRIDES SHASUN LTD With:   GSK PHARMA  FDC LTD.  PLETHICO PHARMA  ASTRAZENECA PHARMA  VENUS REMEDIES  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - NATCO PHARMA COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS